{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:19:37Z","timestamp":1791908377007,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1124\/dmd.123.001492","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T18:40:29Z","timestamp":1701456029000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver Lesions"],"prefix":"10.1016","volume":"52","author":[{"given":"Belle V.","family":"van Rosmalen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5897-0438","authenticated-orcid":false,"given":"Alicia","family":"Furumaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto M.","family":"van Delden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Kazemier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"van Gulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Stieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.123.001492_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrgastro.2014.151","article-title":"Diagnosis and management of solid benign liver lesions","volume":"11","author":"Belghiti","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1124\/dmd.123.001492_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MNM.0b013e32835afe62","article-title":"The use of 18F-fluoromethylcholine PET\/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy","volume":"34","author":"Bieze","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1124\/dmd.123.001492_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.22995","article-title":"Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience","volume":"50","author":"Bioulac-Sage","year":"2009","journal-title":"Hepatology"},{"key":"10.1124\/dmd.123.001492_bib4","series-title":"WHO Classification of Tumours of the Digestive System.","author":"Bosman","year":"2010"},{"key":"10.1124\/dmd.123.001492_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1245\/s10434-008-0275-6","article-title":"Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy","volume":"16","author":"Deneve","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1124\/dmd.123.001492_bib6","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/liv.14212","article-title":"microRNA-206 modulates the hepatic expression of the organic anion-transporting polypeptide 1B1","volume":"39","author":"El Saadany","year":"2019","journal-title":"Liver Int"},{"key":"10.1124\/dmd.123.001492_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","article-title":"EASL clinical practice guidelines on the management of benign liver tumours","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.123.001492_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1148\/radiol.11101742","article-title":"Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis","volume":"262","author":"Grazioli","year":"2012","journal-title":"Radiology"},{"key":"10.1124\/dmd.123.001492_bib9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.mri.2012.11.006","article-title":"Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics","volume":"31","author":"Grieser","year":"2013","journal-title":"Magn Reson Imaging"},{"key":"10.1124\/dmd.123.001492_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/aps.2014.117","article-title":"FXR and liver carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/dmd.123.001492_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/RLI.0b013e3182a70043","article-title":"Characterization of the intestinal and hepatic uptake\/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid","volume":"49","author":"Jia","year":"2014","journal-title":"Invest Radiol"},{"key":"10.1124\/dmd.123.001492_bib12","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/gast.2002.33583","article-title":"Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"122","author":"Jung","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.123.001492_bib13","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3390\/ijms23116046","article-title":"Molecular basis of bile acid-FXR-FGF15\/19 signaling axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.123.001492_bib14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/carcin\/bgl249","article-title":"Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice","volume":"28","author":"Kim","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.123.001492_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2144\/03353bm03","article-title":"Selection of optimal internal controls for gene expression profiling of liver disease","volume":"35","author":"Kim","year":"2003","journal-title":"Biotechniques"},{"key":"10.1124\/dmd.123.001492_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/cells8010031","article-title":"Fibroblast growth factor receptor 4 targeting in cancer: new insights into mechanisms and therapeutic strategies","volume":"8","author":"Lang","year":"2019","journal-title":"Cells"},{"key":"10.1124\/dmd.123.001492_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/dmd.110.032862","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters","volume":"38","author":"Leonhardt","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001492_bib18","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/s41598-021-84960-w","article-title":"Pilot study of gadoxetate disodium-enhanced MRI for localized and metastatic prostate cancers","volume":"11","author":"Lochrin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.123.001492_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0006-291X(02)00182-1","article-title":"In vitro and in vivo hepatic transport of the magnetic resonance imaging contrast agent B22956\/1: role of MRP proteins","volume":"293","author":"Lorusso","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.123.001492_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.gene.2007.04.011","article-title":"Functional analysis on the 5\u2032-flanking region of human FXR gene in HepG2 cells","volume":"396","author":"Lou","year":"2007","journal-title":"Gene"},{"key":"10.1124\/dmd.123.001492_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1148\/radiol.2015142986","article-title":"Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid-enhanced MR imaging\u2014a systematic review","volume":"277","author":"McInnes","year":"2015","journal-title":"Radiology"},{"key":"10.1124\/dmd.123.001492_bib22","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.3390\/ijms23063222","article-title":"HNF1A mutations and beta cell dysfunction in diabetes","volume":"23","author":"Miyachi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.123.001492_bib23","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.123.001492_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00535-009-0056-4","article-title":"Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma","volume":"44","author":"Narita","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1124\/dmd.123.001492_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.29884","article-title":"Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas","volume":"68","author":"Nault","year":"2018","journal-title":"Hepatology"},{"key":"10.1124\/dmd.123.001492_bib26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1124\/dmd.123.001492_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/dmd.113.055707","article-title":"The role of organic anion transporters in diagnosing liver diseases by magnetic resonance imaging","volume":"42","author":"Pastor","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001492_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coph.2018.08.005","article-title":"The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19","volume":"43","author":"Piglionica","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/dmd.123.001492_bib29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1128\/MCB.05988-11","article-title":"Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1\u03b1\/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice","volume":"32","author":"Purushotham","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.123.001492_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/cr.2015.84","article-title":"An HNF1\u03b1-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells","volume":"25","author":"Qian","year":"2015","journal-title":"Cell Res"},{"key":"10.1124\/dmd.123.001492_bib31","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s00330-020-07434-z","article-title":"Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked \u03b2-catenin activation in hepatocellular adenoma","volume":"31","author":"Reizine","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1124\/dmd.123.001492_bib32","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.31557\/APJCP.2023.24.9.3221","article-title":"Interpretation of farnesoid X receptor immunohistochemical expression in discriminating hepatocellular carcinoma from its non-neoplastic mimics as an adjunct to glypican 3","volume":"24","author":"Salama","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1124\/dmd.123.001492_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/liv.13964","article-title":"OATPB1\/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy","volume":"39","author":"Sciarra","year":"2019","journal-title":"Liver Int"},{"key":"10.1124\/dmd.123.001492_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/B978-0-12-800223-0.00005-0","article-title":"Organic anion-transporting polypeptides","volume":"73","author":"Stieger","year":"2014","journal-title":"Curr Top Membr"},{"key":"10.1124\/dmd.123.001492_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","article-title":"Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases","volume":"12","author":"Stoot","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1124\/dmd.123.001492_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1124\/dmd.122.000835","article-title":"Special section on bile acids, drug metabolism, and toxicity\u2014editorial","volume":"50","author":"Supratim Choudhuri","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001492_bib37","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1148\/radiol.10091557","article-title":"Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging\u2014correlation with expression of sinusoidal and canalicular transporters and bile accumulation","volume":"255","author":"Tsuboyama","year":"2010","journal-title":"Radiology"},{"key":"10.1124\/dmd.123.001492_bib38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jhep.2014.06.008","article-title":"OATP1B3 expression is strongly associated with Wnt\/\u03b2-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma","volume":"61","author":"Ueno","year":"2014","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.123.001492_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1148\/radiol.11110023","article-title":"Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification","volume":"261","author":"van Aalten","year":"2011","journal-title":"Radiology"},{"key":"10.1124\/dmd.123.001492_bib40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00259-010-1584-0","article-title":"Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET\/CT","volume":"38","author":"van den Esschert","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1124\/dmd.123.001492_bib41","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/liv.14989","article-title":"Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course","volume":"41","author":"van Rosmalen","year":"2021","journal-title":"Liver Int"},{"key":"10.1124\/dmd.123.001492_bib42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejrad.2005.11.043","article-title":"Focal nodular hyperplasia","volume":"58","author":"Vilgrain","year":"2006","journal-title":"Eur J Radiol"},{"key":"10.1124\/dmd.123.001492_bib43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/dmd.116.072371","article-title":"Impact of organic cation transporters (OCT-SLC22A) on differential diagnosis of intrahepatic lesions","volume":"45","author":"Visentin","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001492_bib44","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","article-title":"Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.123.001492_bib45","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1148\/rg.2016160037","article-title":"Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background","volume":"36","author":"Yoneda","year":"2016","journal-title":"Radiographics"},{"key":"10.1124\/dmd.123.001492_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.120.318141","article-title":"Posttranscriptional regulation of the human ldl receptor by the U2-spliceosome","volume":"130","author":"Zanoni","year":"2022","journal-title":"Circ Res"},{"key":"10.1124\/dmd.123.001492_bib47","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2147\/CMAR.S292197","article-title":"OATP1B3 expression in hepatocellular carcinoma correlates with intralesional Gd-EOB-DTPA uptake and signal intensity on Gd-EOB-DTPA-enhanced MRI","volume":"13","author":"Zhou","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1124\/dmd.123.001492_bib48","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(03)00228-9","article-title":"Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine","volume":"39","author":"Zollner","year":"2003","journal-title":"J Hepatol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562401122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562401122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.123.001492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:06:54Z","timestamp":1739956014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562401122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S009095562401122X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.123.001492","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver Lesions","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.123.001492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}